List of Tables
Table 1. Global PD-1 and PD-L1 Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global PD-1 and PD-L1 Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global PD-1 and PD-L1 Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global PD-1 and PD-L1 Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global PD-1 and PD-L1 Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global PD-1 and PD-L1 Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global PD-1 and PD-L1 Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market PD-1 and PD-L1 Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of PD-1 and PD-L1 Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of PD-1 and PD-L1 Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PD-1 and PD-L1 Drug, Product Type & Application
Table 12. Global Key Manufacturers of PD-1 and PD-L1 Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PD-1 and PD-L1 Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PD-1 and PD-L1 Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global PD-1 and PD-L1 Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global PD-1 and PD-L1 Drug Sales Market Share by Region (2020-2025)
Table 19. Global PD-1 and PD-L1 Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global PD-1 and PD-L1 Drug Sales Market Share by Region (2026-2031)
Table 21. Global PD-1 and PD-L1 Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global PD-1 and PD-L1 Drug Revenue Market Share by Region (2020-2025)
Table 23. Global PD-1 and PD-L1 Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global PD-1 and PD-L1 Drug Revenue Market Share by Region (2026-2031)
Table 25. North America PD-1 and PD-L1 Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America PD-1 and PD-L1 Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America PD-1 and PD-L1 Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America PD-1 and PD-L1 Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America PD-1 and PD-L1 Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe PD-1 and PD-L1 Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe PD-1 and PD-L1 Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe PD-1 and PD-L1 Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe PD-1 and PD-L1 Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe PD-1 and PD-L1 Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific PD-1 and PD-L1 Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific PD-1 and PD-L1 Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific PD-1 and PD-L1 Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific PD-1 and PD-L1 Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific PD-1 and PD-L1 Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America PD-1 and PD-L1 Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America PD-1 and PD-L1 Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America PD-1 and PD-L1 Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America PD-1 and PD-L1 Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America PD-1 and PD-L1 Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa PD-1 and PD-L1 Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa PD-1 and PD-L1 Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa PD-1 and PD-L1 Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa PD-1 and PD-L1 Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa PD-1 and PD-L1 Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global PD-1 and PD-L1 Drug Sales (K Units) by Type (2020-2025)
Table 51. Global PD-1 and PD-L1 Drug Sales (K Units) by Type (2026-2031)
Table 52. Global PD-1 and PD-L1 Drug Sales Market Share by Type (2020-2025)
Table 53. Global PD-1 and PD-L1 Drug Sales Market Share by Type (2026-2031)
Table 54. Global PD-1 and PD-L1 Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global PD-1 and PD-L1 Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global PD-1 and PD-L1 Drug Revenue Market Share by Type (2020-2025)
Table 57. Global PD-1 and PD-L1 Drug Revenue Market Share by Type (2026-2031)
Table 58. Global PD-1 and PD-L1 Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global PD-1 and PD-L1 Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global PD-1 and PD-L1 Drug Sales (K Units) by Application (2020-2025)
Table 61. Global PD-1 and PD-L1 Drug Sales (K Units) by Application (2026-2031)
Table 62. Global PD-1 and PD-L1 Drug Sales Market Share by Application (2020-2025)
Table 63. Global PD-1 and PD-L1 Drug Sales Market Share by Application (2026-2031)
Table 64. Global PD-1 and PD-L1 Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global PD-1 and PD-L1 Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global PD-1 and PD-L1 Drug Revenue Market Share by Application (2020-2025)
Table 67. Global PD-1 and PD-L1 Drug Revenue Market Share by Application (2026-2031)
Table 68. Global PD-1 and PD-L1 Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global PD-1 and PD-L1 Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Bristol Myers Squibb Company Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Bristol Myers Squibb PD-1 and PD-L1 Drug Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. Merck & Co., Inc. Company Information
Table 76. Merck & Co., Inc. Description and Business Overview
Table 77. Merck & Co., Inc. PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Merck & Co., Inc. PD-1 and PD-L1 Drug Product
Table 79. Merck & Co., Inc. Recent Developments/Updates
Table 80. F. Hoffmann -La Roche Ltd Company Information
Table 81. F. Hoffmann -La Roche Ltd Description and Business Overview
Table 82. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product
Table 84. F. Hoffmann -La Roche Ltd Recent Developments/Updates
Table 85. AstraZeneca Company Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. AstraZeneca PD-1 and PD-L1 Drug Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Sanofi PD-1 and PD-L1 Drug Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Pfizer Inc Company Information
Table 96. Pfizer Inc Description and Business Overview
Table 97. Pfizer Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Pfizer Inc PD-1 and PD-L1 Drug Product
Table 99. Pfizer Inc Recent Developments/Updates
Table 100. Lilly Company Information
Table 101. Lilly Description and Business Overview
Table 102. Lilly PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Lilly PD-1 and PD-L1 Drug Product
Table 104. Lilly Recent Developments/Updates
Table 105. Novartis AG Company Information
Table 106. Novartis AG Description and Business Overview
Table 107. Novartis AG PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Novartis AG PD-1 and PD-L1 Drug Product
Table 109. Novartis AG Recent Developments/Updates
Table 110. GSK Company Information
Table 111. GSK Description and Business Overview
Table 112. GSK PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. GSK PD-1 and PD-L1 Drug Product
Table 114. GSK Recent Developments/Updates
Table 115. Junshi Biosciences Company Information
Table 116. Junshi Biosciences Description and Business Overview
Table 117. Junshi Biosciences PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Junshi Biosciences PD-1 and PD-L1 Drug Product
Table 119. Junshi Biosciences Recent Developments/Updates
Table 120. Akeso, Inc Company Information
Table 121. Akeso, Inc Description and Business Overview
Table 122. Akeso, Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Akeso, Inc PD-1 and PD-L1 Drug Product
Table 124. Akeso, Inc Recent Developments/Updates
Table 125. BeiGene Company Information
Table 126. BeiGene Description and Business Overview
Table 127. BeiGene PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. BeiGene PD-1 and PD-L1 Drug Product
Table 129. BeiGene Recent Developments/Updates
Table 130. Innovent Company Information
Table 131. Innovent Description and Business Overview
Table 132. Innovent PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Innovent PD-1 and PD-L1 Drug Product
Table 134. Innovent Recent Developments/Updates
Table 135. Jiangsu Hengrui Medicine Co.,Ltd Company Information
Table 136. Jiangsu Hengrui Medicine Co.,Ltd Description and Business Overview
Table 137. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product
Table 139. Jiangsu Hengrui Medicine Co.,Ltd Recent Developments/Updates
Table 140. Cstone Company Information
Table 141. Cstone Description and Business Overview
Table 142. Cstone PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Cstone PD-1 and PD-L1 Drug Product
Table 144. Cstone Recent Developments/Updates
Table 145. Henlius Company Information
Table 146. Henlius Description and Business Overview
Table 147. Henlius PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Henlius PD-1 and PD-L1 Drug Product
Table 149. Henlius Recent Developments/Updates
Table 150. Simcere Pharmaceutical Group Limited Company Information
Table 151. Simcere Pharmaceutical Group Limited Description and Business Overview
Table 152. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product
Table 154. Simcere Pharmaceutical Group Limited Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. PD-1 and PD-L1 Drug Distributors List
Table 158. PD-1 and PD-L1 Drug Customers List
Table 159. PD-1 and PD-L1 Drug Market Trends
Table 160. PD-1 and PD-L1 Drug Market Drivers
Table 161. PD-1 and PD-L1 Drug Market Challenges
Table 162. PD-1 and PD-L1 Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of PD-1 and PD-L1 Drug
Figure 2. Global PD-1 and PD-L1 Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global PD-1 and PD-L1 Drug Market Share by Type: 2024 & 2031
Figure 4. PD-1 Monoclonal Antibody Product Picture
Figure 5. PD-L1 Monoclonal Antibody Product Picture
Figure 6. Global PD-1 and PD-L1 Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global PD-1 and PD-L1 Drug Market Share by Application: 2024 & 2031
Figure 8. Liver Cancer
Figure 9. Esophageal Cancer
Figure 10. Nasal Cancer
Figure 11. Stomach Cancer
Figure 12. Other
Figure 13. Global PD-1 and PD-L1 Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global PD-1 and PD-L1 Drug Market Size (2020-2031) & (US$ Million)
Figure 15. Global PD-1 and PD-L1 Drug Sales (2020-2031) & (K Units)
Figure 16. Global PD-1 and PD-L1 Drug Average Price (US$/Unit) & (2020-2031)
Figure 17. PD-1 and PD-L1 Drug Report Years Considered
Figure 18. PD-1 and PD-L1 Drug Sales Share by Manufacturers in 2024
Figure 19. Global PD-1 and PD-L1 Drug Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest PD-1 and PD-L1 Drug Players: Market Share by Revenue in PD-1 and PD-L1 Drug in 2024
Figure 21. PD-1 and PD-L1 Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global PD-1 and PD-L1 Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America PD-1 and PD-L1 Drug Sales Market Share by Country (2020-2031)
Figure 24. North America PD-1 and PD-L1 Drug Revenue Market Share by Country (2020-2031)
Figure 25. United States PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe PD-1 and PD-L1 Drug Sales Market Share by Country (2020-2031)
Figure 28. Europe PD-1 and PD-L1 Drug Revenue Market Share by Country (2020-2031)
Figure 29. Germany PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific PD-1 and PD-L1 Drug Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific PD-1 and PD-L1 Drug Revenue Market Share by Region (2020-2031)
Figure 36. China PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America PD-1 and PD-L1 Drug Sales Market Share by Country (2020-2031)
Figure 44. Latin America PD-1 and PD-L1 Drug Revenue Market Share by Country (2020-2031)
Figure 45. Mexico PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa PD-1 and PD-L1 Drug Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa PD-1 and PD-L1 Drug Revenue Market Share by Country (2020-2031)
Figure 50. Turkey PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE PD-1 and PD-L1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of PD-1 and PD-L1 Drug by Type (2020-2031)
Figure 54. Global Revenue Market Share of PD-1 and PD-L1 Drug by Type (2020-2031)
Figure 55. Global PD-1 and PD-L1 Drug Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of PD-1 and PD-L1 Drug by Application (2020-2031)
Figure 57. Global Revenue Market Share of PD-1 and PD-L1 Drug by Application (2020-2031)
Figure 58. Global PD-1 and PD-L1 Drug Price (US$/Unit) by Application (2020-2031)
Figure 59. PD-1 and PD-L1 Drug Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
